Managing Director Salary Guide 2026: UK Rates, Package Structures and Benchmarks

Managing Director Salary Guide 2026: UK Rates, Package Structures and Benchmarks

Managing Director compensation in the UK varies more by ownership structure, business scale and sector than by any other single variable. An MD at a £10m revenue owner-managed business and an MD at a £150m PE-backed portfolio company may carry the same title, but their packages differ by a factor of three to five across base salary, bonus potential and long-term incentive value. This guide sets out current UK MD compensation benchmarks, the structure of typical packages, the factors that most materially affect positioning within ranges, and the role of the search process in package construction.

The figures in this guide are drawn from Managing Director searches conducted by Exec Capital and FD Capital during 2025 and 2026 across UK owner-managed, PE-backed, listed-subsidiary and regulated businesses. They represent mid-market current rates for experienced MD candidates, not floor rates for first-time appointments or ceiling rates for the most senior appointments in constrained markets.

For C-suite salary benchmarks more broadly, see our C-Suite Salary Guide. For PE-backed business compensation, see our Private Equity Salary Guide. For director-level benchmarks across all functions, see our Directors Salary Guide.

How these figures are compiled

Exec Capital compiles compensation benchmarks from three primary sources: current and recently completed MD searches, where offer-stage and acceptance-stage data reflects actual market transactions; candidate-supplied compensation data gathered during the search process (with candidate consent and in anonymised aggregate form); and professional network intelligence from the ICAEW, the Chartered Management Institute and sector-specific professional bodies.

We do not rely primarily on published salary surveys, which typically lag current market conditions by twelve to twenty-four months and are based on self-reported data from a self-selected respondent pool. The figures in this guide reflect current transaction data from live mandates, which produces more accurate point-in-time benchmarks for use in search briefs and offer construction.

One important caveat: compensation benchmarks are market reference points, not targets. Specific MD packages are determined by the interaction of the candidate’s current total compensation, the specific brief, the ownership structure’s constraints and incentives, and the competitive dynamics of the search at offer stage. The ranges below provide context for that interaction, not a formula for substituting it.

Owner-managed business MD salary ranges 2026

Owner-managed businesses — those with a founding owner or family ownership where there is no institutional investment — represent the largest single segment of UK MD hiring by volume. Compensation at this level is driven by the business’s ability to fund the package within its existing cost structure, the founder’s view of appropriate remuneration relative to their own returns, and the competitive dynamics of the candidate pool the business is trying to access.

Revenue £3m–£15m

Base salary: £75,000–£120,000. At the lower end of this revenue range, the MD role is typically the first senior hire outside the founding team, and the package is constrained by the business’s cost structure and the founder’s compensation expectations. Candidates with demonstrable track records of running businesses at this scale and above will typically require packages at or above £100,000 base.

Annual bonus: 10–20% of base salary, typically discretionary and founder-determined. Structured bonus plans tied to specific financial metrics are less common at this revenue scale. Some businesses use profit-share arrangements rather than formal bonus structures.

Long-term incentive: Rare at this scale, though phantom equity (a contractual right to a defined percentage of the business’s equity value at exit) is occasionally used to attract and retain MDs in businesses with credible exit potential.

Revenue £15m–£50m

Base salary: £110,000–£175,000. The mid-point of UK owner-managed MD compensation. At this revenue range, the MD role carries material team leadership, P&L ownership and board relationship responsibilities that justify a more structured package.

Annual bonus: 15–30% of base, increasingly structured against EBITDA improvement, revenue growth or a blend of financial and operational targets. Boards at this revenue scale have typically moved beyond fully discretionary bonus to structured plans with defined metrics, even if the measurement is informal.

Long-term incentive: Beginning to formalise at this scale. Phantom equity plans, profit-share arrangements over rolling three-year periods, and (in businesses approaching PE investment or sale) share option schemes tied to the anticipated exit are used to retain MDs through the business’s most commercially important phase.

Revenue £50m–£150m

Base salary: £160,000–£250,000. At this revenue scale, the MD role in an owner-managed business typically carries the full suite of commercial, operational and governance responsibilities. The candidate pool at this level is international, and UK candidates with directly relevant track records are in genuine demand.

Annual bonus: 20–40% of base, structured against EBITDA, revenue and strategic objectives. Annual bonus payments at the top of this range can be material in absolute terms (£60,000–£100,000+ at 40% of a £200,000 base), making total cash compensation the most important negotiating variable.

Long-term incentive: Standard at this revenue scale. Phantom equity plans with defined triggers tied to sale or exit, rolling profit-share pools, and (increasingly) EMI option schemes are all used. The long-term incentive quantum is often the most contentious element of offer negotiation for MDs at this scale.

PE-backed business MD salary ranges 2026

PE-backed MD compensation packages are structured materially differently from owner-managed equivalents, because the primary long-term value creation mechanism is equity participation in the business rather than cash compensation. The cash package at a PE-backed business is typically competitive with, but not dramatically above, the equivalent owner-managed package. The long-term incentive is where the PE-backed MD package differs fundamentally.

Enterprise value £20m–£75m

Base salary: £120,000–£175,000. PE houses at this end of the market are typically growth equity or lower-mid-market buyout funds where operating cost discipline is a primary focus. MD base salaries reflect this, and are often set deliberately below what the same individual might earn in an equivalent owner-managed role in order to preserve equity upside as the primary incentive alignment mechanism.

Annual bonus: 25–40% of base, structured against EBITDA improvement, revenue growth and specific value-creation plan milestones. PE bonus structures typically have higher gearing than owner-managed bonus schemes — the upside for exceptional performance is greater, and the downside for underperformance is more sharply felt.

Sweet equity / MIP: Typically 3–7% of the management equity pool. At a £40m enterprise value investment with 2.5× value creation over five years, a 5% sweet equity allocation generates approximately £750,000–£1.5m of pre-tax exit proceeds, depending on the structure. This is the primary incentive for strong candidates to accept PE-backed roles at lower cash packages than they might achieve elsewhere.

Enterprise value £75m–£250m

Base salary: £175,000–£240,000. Mid-market PE-backed MD packages move into a range where the annual cash component is genuinely competitive with larger owner-managed businesses. At the upper end of this range, total cash compensation (base plus on-target bonus) can reach £350,000–£400,000, though the equity remains the primary long-term incentive.

Annual bonus: 30–50% of base. At this scale, PE houses typically use more sophisticated bonus structures with multiple financial and strategic metrics, cliff provisions for below-threshold performance, and accelerators for exceptional performance against the value-creation plan.

Sweet equity / MIP: 3–6% of the management equity pool. Co-investment rights are offered at the more senior end of this range, allowing the MD to invest their own capital alongside the fund at deal terms, generating additional equity exposure beyond the sweet equity allocation.

Enterprise value £250m+

Base salary: £220,000–£350,000+. Upper-mid-market and large-cap PE-backed MD packages are competitive with listed company equivalents on cash, with the equity component representing the primary additional upside.

Annual bonus: 40–60% of base. At this scale, annual bonus is a material cash number in its own right (£100,000–£200,000 at on-target), though the exit equity remains the defining component of total compensation over the investment period.

Sweet equity / MIP: 2–5% of management pool. Co-investment rights standard at this scale. For the full economics of PE management equity, including Section 431 elections, BADR qualifying conditions and good leaver/bad leaver provisions, see our Sweet Equity for PE Management Teams guide and our BADR and Section 431 guide.

Listed company subsidiary and group MD salary ranges 2026

MDs of listed company subsidiaries or operating divisions are typically compensated within the parent group’s remuneration framework, which is subject to the remuneration committee’s oversight and the Investment Association’s remuneration principles. The MD of a subsidiary does not typically participate in the group LTIP but may have a divisional incentive scheme.

Division turnover £20m–£75m: Base salary £120,000–£185,000. Annual bonus 20–35% of base against divisional P&L targets. No LTIP; some businesses use phantom equity or matching share schemes tied to group performance.

Division turnover £75m–£200m: Base salary £175,000–£250,000. Annual bonus 30–50% of base. In some listed groups, subsidiary MDs participate in shadow LTIP schemes that mirror the group’s LTIP structure at divisional level.

Package structure components in detail

Beyond the headline base salary, MD packages in the UK typically include the following components:

Annual bonus. The most variable component. Most MD bonus structures are calculated against a combination of EBITDA improvement (or revenue where EBITDA is less controllable by the MD), strategic objectives and individual performance targets. The split between financial and non-financial targets varies by business stage: growth businesses weight toward revenue and new customer acquisition; mature businesses toward margin improvement and cash generation. Threshold-to-maximum ranges of 0–150% of on-target are common at senior MD level.

Pension. Employer pension contributions of 5–10% of base salary are standard for UK MD appointments. Higher contribution rates (10–15%) are sometimes used as a mechanism for increasing total package value within a base salary constraint, particularly for candidates who are already close to the annual pension allowance limit. See HMRC guidance on the pension annual allowance for the current limits and tapering rules relevant to senior earners.

Car allowance. £7,500–£15,000 per annum or a company car at most MD levels. Electric vehicle salary sacrifice schemes are increasingly used as part of total package structuring given the benefit-in-kind tax advantages relative to petrol and diesel vehicles. The UK Government’s guidance on electric vehicle salary sacrifice sets out the current tax treatment.

Private medical insurance. Standard in UK senior packages. Family cover at senior MD level is the norm. The cost to the employer ranges from £2,500 to £8,000 per annum for individual cover, more for family cover, and is a taxable benefit in kind.

Notice period. Twelve months is the standard contractual notice period for MD roles in UK mid-market businesses. Six months is common for smaller businesses and for MDs in their first role at that level. Eighteen months is occasionally offered in listed-subsidiary and larger PE-backed roles but is increasingly uncommon following post-pandemic norm adjustments. Garden leave provisions and restrictive covenant packages — non-compete, non-solicit — interact with notice period in ways that affect the total severance exposure and the practical mobility of the individual. See our Restrictive Covenants and Garden Leave guide for the full treatment.

Long-term incentive. As described above, varies significantly by ownership structure. In owner-managed businesses without a defined exit horizon, formal LTI structures are less common but phantom equity, profit-share over rolling periods and earn-out structures tied to sale processes are used to retain key MDs. In PE-backed businesses, sweet equity participation is the primary LTI mechanism. In listed companies, LTIP schemes at group level or divisional equivalents are standard.

Factors that move MD compensation within the range

Six factors most reliably move individual MD packages away from the mid-point of the range for their business type and scale:

Sector premium. Financial services, technology and professional services MD roles command a 15–25% premium over retail, manufacturing and construction equivalents at equivalent revenue scale. This reflects both the compensation cultures of those sectors and the competition for candidates who have operated successfully within them.

Search complexity and candidate scarcity. Where the MD brief requires a combination of attributes that is genuinely rare — sector-specific regulatory knowledge, international market experience, transformation track record at a specific scale — the competition for candidates narrows and packages rise accordingly. The clearest signal of genuine candidate scarcity is multiple businesses pursuing the same shortlist simultaneously.

Urgency premium. MDs appointed under compressed timelines — where the business is covering an unplanned gap, managing an adverse trading situation or preparing for a time-sensitive transaction — often command a 10–20% premium on base salary, reflecting both the scarcity of available candidates at short notice and the commercial risk the incoming MD is absorbing by joining a business in a difficult position.

Equity participation offer. Owner-managed businesses that offer equity participation alongside a competitive cash package can attract stronger candidates than the cash package alone suggests. The equity offer must be credible, specific and clearly valued for it to function as a compensation mechanism rather than an aspiration. Candidates receiving equity offers will typically have them reviewed by advisers, and vague or poorly structured equity offers are usually not compensatory.

Candidate’s current package. The starting point for most MD offer negotiations is the candidate’s current total compensation. Offers that require candidates to move for less than their current total compensation, without a compelling equity or strategic reason, will typically not be accepted. Understanding the candidate’s current package before shortlisting — not after — avoids the most common cause of offer-stage failure.

Geographic location and remote working expectation. MD packages in London and the South East carry a premium over equivalent roles in other UK regions, reflecting both higher candidate compensation expectations and higher cost of living. The emergence of hybrid working models has narrowed this premium for roles where the MD does not need to be on-site daily, but fully remote MD roles remain unusual at senior level, and roles requiring five days per week in a non-London location face specific candidate pool constraints.

Negotiating MD packages: what Exec Capital builds into every search

Exec Capital builds compensation benchmarking into every Managing Director search mandate before the first candidate is approached. The benchmark is drawn from current market intelligence from active and recently completed mandates at comparable business scale and ownership context. Where the proposed package falls below current market rates for the candidate profile the brief requires, we flag this at the start of the search rather than at the point when the preferred candidate reveals their expectations.

At offer stage, Exec Capital manages the offer construction and negotiation process on behalf of the client. This includes structuring the package across its components to maximise the candidate’s net benefit within the client’s total cost constraint, advising on the sequencing of conversations about compensation, and managing the reference to the candidate’s current package in a way that anchors the negotiation appropriately.

For a discussion of your specific compensation context, including how to structure a package that attracts the MD profile your brief requires within your financial constraints, contact Exec Capital using the details below.

Further reading

For the full MD hiring process, see our How to Hire a Managing Director guide. For the attributes and assessment framework, see our What Makes a Great Managing Director guide. For the succession planning process, see our MD Succession Planning guide. For the decision framework, see our When to Hire a Managing Director guide.

For PE-backed business compensation, including sweet equity economics and co-investment structures, see our Sweet Equity for PE Management Teams guide, our Co-Investment and Carry guide and our Executive Compensation guide.

External resources: the ONS earnings and working hours data provides macro context for UK earnings trends. The Chartered Management Institute’s research reports include periodic analysis of senior management compensation in the UK mid-market.